CardioExchange Archive

December 27th, 2013

2013 In Review: Our Top 12 Posts

Harlan M. Krumholz, MD, SM and CardioExchange Editors, Staff

After an incredibly busy year we took a moment to reflect on our top stories. In no particular order, these are among the most viewed posts on CardioExchange over the past year. My personal favorite of the year was Victor Montori’s questioning of PRAMI. Take a look and let us know what was your favorite feature […]

---

December 16th, 2013

Three Cases of Sudden Cardiac Death Linked to Lyme Carditis

CardioExchange Editors, Staff

Three cases of sudden cardiac death associated with Lyme carditis were reported in 2012 and 2013 and are described in MMWR. Only four such deaths have previously been reported. The three patients, aged 26 to 38, lived in states with a high incidence of Lyme disease. None had rash; two had pre-existing heart conditions. Postmortem investigation […]

---

November 6th, 2013

Why Amarin Has To Finish Its Big Fish Oil Study

CardioExchange Editors, Staff

The following post is by Matt Herper, who covers science and medicine for Forbes magazine. When a panel of experts appointed by the Food and Drug Administration said the agency should deny Amarin Pharmaceuticals a broader marketing approval for its fish oil pill Vascepa, the company’s shares tanked 60%, making it the worst-performing biotechnology stock on […]

---

September 22nd, 2013

Join a Conversation About Health Care Innovation

CardioExchange Editors, Staff

Join the conversation launched by The New England Journal of Medicine and Harvard Business Review about the future of health care innovation.

---

September 1st, 2013

ESC.13 Headquarters

CardioExchange Editors, Staff

Find all of our ESC.13 coverage here.

---

March 9th, 2013

ACC.13 Headquarters

CardioExchange Editors, Staff

CardioExchange is dedicated to bringing you the latest from ACC.13. Check out our coverage below ─ and some of the great debates these posts have sparked ─ then tell us what you think! News: Following an Embargo Break PREVAIL Trial Won’t be Presented at ACC HPS2-THRIVE: A ‘Disappointing But Clear’ Result Cangrelor During PCI May Reduce […]

---

December 21st, 2012

A Look Forward to 2013

CardioExchange Editors, Staff

CardioExchange invited contributors and members to offer predictions for 2013. Several of these folks also offered predictions for last year and helped assess the most important developments in cardiology in 2012. What are your predictions for the year?   Steven E Nissen, MD The IMPROVE-IT Trial will complete and show no reduction in morbidity-mortality with addition of ezetimibe to simvastatin The […]

---

December 21st, 2012

A Look Back at 2012

CardioExchange Editors, Staff

CardioExchange invited several members and participants to give us a list of what they consider the top three most important developments in cardiology in 2012.  The same CardioExchange members offer predictions for 2013, which you can view here. Also, for comparison, check out last year’s predictions for 2012 to see which came to fruition. What would your choices have […]

---

November 5th, 2012

AHA 2012 Headquarters

CardioExchange Editors, Staff

CardioExchange is dedicated to bringing you the latest from AHA 2012 and it can all be found right here.

---

October 30th, 2012

Ablation for Treatment-Naive A-Fib Patients?

CardioExchange Editors, Staff

Younger, healthier treatment-naive patients with a-fib can be offered initial ablation therapy, although drug therapy remains the default, according to the authors of this recent study in the NEJM.

---